AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
On July 22, 2025, Beyond Air's stock surged by 5.42% in pre-market trading, marking a significant rise that has caught the attention of investors and analysts alike.
Beyond Air has secured a premier contract with Premier, Inc., granting the company access to two-thirds of the U.S. hospital market. This agreement is expected to streamline the adoption process for Beyond Air's innovative cylinder-free nitric oxide system, which is designed to improve patient outcomes and operational efficiency in hospitals.
Beyond Air's LungFit, a cylinder-free, phasic flow generator and delivery system, has been designated as a medical device by the U.S. Food and Drug Administration (FDA). This designation underscores the company's commitment to developing cutting-edge medical technologies that address critical healthcare needs.

Get the scoop on pre-market movers and shakers in the US stock market.

Dec.17 2025

Dec.17 2025

Dec.17 2025

Dec.17 2025

Dec.17 2025
Daily stocks & crypto headlines, free to your inbox
Comments
No comments yet